Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia

Stefan D. Anker; Tuan Peng Chua; Piotr Ponikowski; Derek Harrington; Jon W. Swan; Wolfgang J. Kox; Philip A. Poole-Wilson; Andrew J S Coats

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia

Stefan D. Anker, Tuan Peng Chua, Piotr Ponikowski, Derek Harrington, Jon W. Swan, Wolfgang J. Kox, Philip A. Poole-Wilson, Andrew J S Coats

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Abstract

Background: The role of hormonal and cytokine abnormalities in the development of cardiac cachexia remains obscure. Methods and Results: Healthy control subjects (n=16) and patients with chronic heart failure (CHF), classified clinically as cachectic (8% to 35% weight loss over ≤6 months before study, n=16) or noncachectic (n=37), were assessed for markers of disease severity (maximal oxygen consumption, left ventricular ejection fraction, NYHA functional class). These markers were compared with plasma concentrations of potentially important anabolic and catabolic factors. The degree of neurohormonal activation and catabolic/anabolic imbalance was closely related to wasting but not to conventional measures of the severity of heart failure. Compared with control subjects and noncachectic patients, cachectic patients had reduced plasma sodium and increased norepinephrine, epinephrine (all P2=.50, P

Original language	English
Pages (from-to)	526-534
Number of pages	9
Journal	Circulation
Volume	96
Issue number	2
Publication status	Published - Jul 15 1997

Keywords

Cachexia
Catecholamines
Heart failure
Hormones
Metabolism

ASJC Scopus subject areas

Physiology
Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia'. Together they form a unique fingerprint.

Cite this

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. / Anker, Stefan D.; Chua, Tuan Peng; Ponikowski, Piotr; Harrington, Derek; Swan, Jon W.; Kox, Wolfgang J.; Poole-Wilson, Philip A.; Coats, Andrew J S.

In: Circulation, Vol. 96, No. 2, 15.07.1997, p. 526-534.

Research output: Contribution to journal › Article › peer-review

@article{4910d7fa237e4147ac9de6da346e981c,

title = "Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia",

abstract = "Background: The role of hormonal and cytokine abnormalities in the development of cardiac cachexia remains obscure. Methods and Results: Healthy control subjects (n=16) and patients with chronic heart failure (CHF), classified clinically as cachectic (8% to 35% weight loss over ≤6 months before study, n=16) or noncachectic (n=37), were assessed for markers of disease severity (maximal oxygen consumption, left ventricular ejection fraction, NYHA functional class). These markers were compared with plasma concentrations of potentially important anabolic and catabolic factors. The degree of neurohormonal activation and catabolic/anabolic imbalance was closely related to wasting but not to conventional measures of the severity of heart failure. Compared with control subjects and noncachectic patients, cachectic patients had reduced plasma sodium and increased norepinephrine, epinephrine (all P2=.50, P",

keywords = "Cachexia, Catecholamines, Heart failure, Hormones, Metabolism",

author = "Anker, {Stefan D.} and Chua, {Tuan Peng} and Piotr Ponikowski and Derek Harrington and Swan, {Jon W.} and Kox, {Wolfgang J.} and Poole-Wilson, {Philip A.} and Coats, {Andrew J S}",

year = "1997",

month = jul,

day = "15",

language = "English",

volume = "96",

pages = "526--534",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia

AU - Anker, Stefan D.

AU - Chua, Tuan Peng

AU - Ponikowski, Piotr

AU - Harrington, Derek

AU - Swan, Jon W.

AU - Kox, Wolfgang J.

AU - Poole-Wilson, Philip A.

AU - Coats, Andrew J S

PY - 1997/7/15

Y1 - 1997/7/15

N2 - Background: The role of hormonal and cytokine abnormalities in the development of cardiac cachexia remains obscure. Methods and Results: Healthy control subjects (n=16) and patients with chronic heart failure (CHF), classified clinically as cachectic (8% to 35% weight loss over ≤6 months before study, n=16) or noncachectic (n=37), were assessed for markers of disease severity (maximal oxygen consumption, left ventricular ejection fraction, NYHA functional class). These markers were compared with plasma concentrations of potentially important anabolic and catabolic factors. The degree of neurohormonal activation and catabolic/anabolic imbalance was closely related to wasting but not to conventional measures of the severity of heart failure. Compared with control subjects and noncachectic patients, cachectic patients had reduced plasma sodium and increased norepinephrine, epinephrine (all P2=.50, P

AB - Background: The role of hormonal and cytokine abnormalities in the development of cardiac cachexia remains obscure. Methods and Results: Healthy control subjects (n=16) and patients with chronic heart failure (CHF), classified clinically as cachectic (8% to 35% weight loss over ≤6 months before study, n=16) or noncachectic (n=37), were assessed for markers of disease severity (maximal oxygen consumption, left ventricular ejection fraction, NYHA functional class). These markers were compared with plasma concentrations of potentially important anabolic and catabolic factors. The degree of neurohormonal activation and catabolic/anabolic imbalance was closely related to wasting but not to conventional measures of the severity of heart failure. Compared with control subjects and noncachectic patients, cachectic patients had reduced plasma sodium and increased norepinephrine, epinephrine (all P2=.50, P

KW - Cachexia

KW - Catecholamines

KW - Heart failure

KW - Hormones

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=0342460492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342460492&partnerID=8YFLogxK

M3 - Article

C2 - 9244221

AN - SCOPUS:0342460492

VL - 96

SP - 526

EP - 534

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2

ER -